Radioembolisation With Yttrium‒90 Microspheres Versus Sorafenib for Treatment of Advanced Hepatocellular Carcinoma (SARAH): Study Protocol for a Randomised Controlled Trial

Trials - United Kingdom
doi 10.1186/1745-6215-15-474
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Treatment of Inoperable Hepatocellular Carcinoma With Intrahepatic Arterial Yttrium-90 Microspheres: A Phase I and II Study

British Journal of Cancer
Cancer ResearchOncology
1994English

Yttrium-90 Radioembolization Versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Comparative Analysis

HPB
HepatologyGastroenterology
2016English

Operative Treatment of Intra-Articular Distal Radius Fractures With Versus Without Arthroscopy: Study Protocol for a Randomised Controlled Trial

Trials
MedicinePharmacology
2018English

Sorafenib Alone Versus Sorafenib Combined With Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses

Radiology
Nuclear MedicineRadiologyImaging
2013English

Randomized, Phase II Trial of Sequential Hepatic Arterial Infusion Chemotherapy and Sorafenib Versus Sorafenib Alone as Initial Therapy for Advanced Hepatocellular Carcinoma: SCOOP-2 Trial

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Multicentre Randomised Trial of Acute Stroke Treatment in the Ambulance With a Nitroglycerin Patch (MR ASAP): Study Protocol for a Randomised Controlled Trial

Trials
MedicinePharmacology
2019English

Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Acupuncture for Menopausal Vasomotor Symptoms: Study Protocol for a Randomised Controlled Trial

Trials
MedicinePharmacology
2014English

The Y-Worri Project: Study Protocol for a Randomised Controlled Trial

Trials
MedicinePharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy